Skip to main content
. 2022 Mar 30;13:856493. doi: 10.3389/fgene.2022.856493

TABLE 1.

Genotype and allele frequencies of five CLEC16A variants in PD patients and controls.

Variant Genotype, n (%) P Allele, n (%) P OR (95%CI)
rs6498169 GG GA AA 0.005 a G A 0.042 1.199 (1.007–1.427)
Control 151 (30.0) 264 (52.4) 89 (17.7) 566 (56.2) 442 (43.8)
PD 150 (29.1) 232 (45.0) 133 (25.8) 532 (51.7) 498 (48.3)
rs12708716 AA AG GG 0.430 A G 0.288 1.116 (0.912–1.366)
Control 293 (58.1) 186 (36.9) 25 (5.0) 772 (76.6) 236 (23.4)
PD 288 (55.9) 192 (37.3) 35 (6.8) 768 (74.6) 262 (25.4)
rs12917716 GG GC CC 0.055 G C 0.026 1.221 (1.024–1.456)
Control 173 (34.3) 258 (51.2) 73 (14.5) 604 (59.9) 404 (40.1)
PD 154 (29.9) 259 (50.3) 102 (19.8) 567 (55.0) 463 (45.0)
rs7200786 AA AG GG 0.004 a A G 0.044 1.207 (1.005–1.448)
Control 220 (43.7) 239 (47.4) 45 (8.9) 679 (67.4) 329 (32.6)
PD 216 (41.9) 218 (42.3) 81 (15.7) 650 (63.1) 380 (36.9)
rs2903692 GG GA AA 0.731 G A 0.732 1.036 (0.846–1.268)
Control 289 (57.3) 188 (37.3) 27 (5.4) 766 (76.0) 242 (24.0)
PD 286 (55.5) 204 (39.6) 25 (4.9) 776 (75.3) 254 (24.7)
a

P < 0.01. CI, confidence interval; OR, odds ratio; PD, Parkinson’s disease.